Galapagos NV (GLPG)
USD 23.52
(2.08%)
USD 23.52
(2.08%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.56 Billion EUR | -29.28% |
| 2022 | 2.2 Billion EUR | -13.39% |
| 2021 | 2.54 Billion EUR | -16.33% |
| 2020 | 3.04 Billion EUR | -4.56% |
| 2019 | 3.19 Billion EUR | 1317.53% |
| 2018 | 225.24 Million EUR | -17.88% |
| 2017 | 274.29 Million EUR | -15.51% |
| 2016 | 324.63 Million EUR | 318.81% |
| 2015 | 77.51 Million EUR | 20.49% |
| 2014 | 64.33 Million EUR | -46.5% |
| 2013 | 120.23 Million EUR | 2.87% |
| 2012 | 116.88 Million EUR | 173.86% |
| 2011 | 42.67 Million EUR | -6.11% |
| 2010 | 45.45 Million EUR | 30.49% |
| 2009 | 34.83 Million EUR | 0.96% |
| 2008 | 34.5 Million EUR | -31.13% |
| 2007 | 50.09 Million EUR | -13.78% |
| 2006 | 58.1 Million EUR | 184.45% |
| 2005 | 20.42 Million EUR | 289.38% |
| 2004 | 5.24 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.46 Billion EUR | -6.11% |
| 2024 Q2 | 1.38 Billion EUR | -5.89% |
| 2023 Q4 | 1.56 Billion EUR | -14.64% |
| 2023 Q1 | 2.06 Billion USD | -6.37% |
| 2023 Q3 | 1.82 Billion EUR | -5.6% |
| 2023 Q2 | 1.93 Billion EUR | -6.25% |
| 2023 FY | 1.56 Billion EUR | -29.28% |
| 2022 Q3 | 2.28 Billion EUR | -4.66% |
| 2022 Q4 | 2.2 Billion EUR | -3.22% |
| 2022 FY | 2.2 Billion EUR | -13.39% |
| 2022 Q1 | 2.45 Billion EUR | -3.77% |
| 2022 Q2 | 2.39 Billion EUR | -2.47% |
| 2021 Q4 | 2.54 Billion EUR | -6.07% |
| 2021 FY | 2.54 Billion EUR | -16.33% |
| 2021 Q2 | 2.76 Billion EUR | -5.03% |
| 2021 Q3 | 2.71 Billion EUR | -1.9% |
| 2021 Q1 | 2.91 Billion EUR | -4.39% |
| 2020 Q3 | 3 Billion EUR | -2.25% |
| 2020 Q1 | 3.15 Billion EUR | -1.27% |
| 2020 FY | 3.04 Billion EUR | -4.56% |
| 2020 Q4 | 3.04 Billion EUR | 1.28% |
| 2020 Q2 | 3.07 Billion EUR | -2.35% |
| 2019 Q1 | 224.44 Million EUR | -0.36% |
| 2019 Q4 | 3.19 Billion EUR | -3.72% |
| 2019 FY | 3.19 Billion EUR | 1317.53% |
| 2019 Q2 | 214.48 Million EUR | -4.44% |
| 2019 Q3 | 3.31 Billion EUR | 1446.28% |
| 2018 Q1 | 330.51 Million EUR | 20.5% |
| 2018 FY | 225.24 Million EUR | -17.88% |
| 2018 Q4 | 225.24 Million EUR | -24.24% |
| 2018 Q3 | 297.32 Million EUR | -6.7% |
| 2018 Q2 | 318.68 Million EUR | -3.58% |
| 2017 Q2 | 299.32 Million EUR | -7.8% |
| 2017 FY | 274.29 Million EUR | -15.51% |
| 2017 Q1 | 324.66 Million EUR | 0.01% |
| 2017 Q3 | 154.53 Million EUR | -48.37% |
| 2017 Q4 | 274.29 Million EUR | 77.5% |
| 2016 Q2 | 336.72 Million EUR | -4.0% |
| 2016 Q4 | 324.63 Million EUR | -2.88% |
| 2016 FY | 324.63 Million EUR | 318.81% |
| 2016 Q3 | 334.27 Million EUR | -0.73% |
| 2016 Q1 | 350.74 Million EUR | 352.48% |
| 2015 Q1 | - EUR | -100.0% |
| 2015 Q4 | 77.51 Million EUR | 83.43% |
| 2015 Q3 | 42.25 Million EUR | -5.69% |
| 2015 Q2 | 44.8 Million EUR | 0.0% |
| 2015 FY | 77.51 Million EUR | 20.49% |
| 2014 Q4 | 64.33 Million EUR | 0.0% |
| 2014 FY | 64.33 Million EUR | -46.5% |
| 2014 Q2 | 79.96 Million EUR | -0.03% |
| 2014 Q1 | 79.99 Million EUR | -33.47% |
| 2013 Q1 | 108.21 Million EUR | -7.41% |
| 2013 Q4 | 120.23 Million EUR | 0.0% |
| 2013 FY | 120.23 Million EUR | 2.87% |
| 2013 Q2 | 108.21 Million EUR | 0.0% |
| 2013 Q3 | 120.23 Million EUR | 11.11% |
| 2012 Q3 | 109.01 Million EUR | -16.78% |
| 2012 Q4 | 116.88 Million EUR | 7.22% |
| 2012 Q2 | 130.99 Million EUR | 0.0% |
| 2012 FY | 116.88 Million EUR | 173.86% |
| 2011 Q2 | 34.69 Million EUR | 0.0% |
| 2011 Q4 | 42.67 Million EUR | 0.0% |
| 2011 FY | 42.67 Million EUR | -6.11% |
| 2010 Q2 | 36.55 Million EUR | 0.0% |
| 2010 FY | 45.45 Million EUR | 30.49% |
| 2010 Q4 | 45.45 Million EUR | 0.0% |
| 2009 FY | 34.83 Million EUR | 0.96% |
| 2009 Q2 | 26.97 Million EUR | 0.0% |
| 2009 Q4 | 34.83 Million EUR | 0.0% |
| 2008 Q4 | 34.5 Million EUR | 0.0% |
| 2008 FY | 34.5 Million EUR | -31.13% |
| 2007 FY | 50.09 Million EUR | -13.78% |
| 2006 FY | 58.1 Million EUR | 184.45% |
| 2005 FY | 20.42 Million EUR | 289.38% |
| 2004 FY | 5.24 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 272.28 Million USD | -473.597% |
| Jaguar Health, Inc. | 45.86 Million USD | -3305.202% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -4030.514% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -15879.435% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 61.441% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1094.909% |
| ContextLogic Inc. | 206 Million USD | -658.17% |
| MiMedx Group, Inc. | 96.33 Million USD | -1521.333% |
| MEI Pharma, Inc. | 8.35 Million USD | -18593.357% |
| AlloVir, Inc. | 45.01 Million USD | -3369.577% |
| Novavax, Inc. | 2.57 Billion USD | 39.282% |
| Aptorum Group Limited | 5.25 Million USD | -29611.011% |
| Ardelyx, Inc. | 130.76 Million USD | -1094.397% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -226.476% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -12802.675% |
| Vaxcyte, Inc. | 167.44 Million USD | -832.72% |
| Precigen, Inc. | 41.64 Million USD | -3650.432% |
| Pharming Group N.V. | 244.07 Million USD | -539.903% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -220.967% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -13000.403% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -970.707% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1122.175% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -44158.43% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -23538.021% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -23538.021% |
| Bicycle Therapeutics plc | 224.41 Million USD | -595.965% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1794.666% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -23410.914% |
| Acelyrin, Inc. | 86.35 Million USD | -1708.657% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -10761.882% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -16376.738% |
| Senti Biosciences, Inc. | 52.57 Million USD | -2870.897% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -2170.861% |
| AbCellera Biologics Inc. | 335.77 Million USD | -365.14% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -79748.16% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1099.47% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -588.54% |
| Chimerix, Inc. | 19.74 Million USD | -7810.003% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -16573.748% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -5282.836% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -4339.904% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -3970.127% |
| Elevation Oncology, Inc. | 34.28 Million USD | -4455.831% |
| Alkermes plc | 933.53 Million USD | -67.302% |
| Fortress Biotech, Inc. | 165.93 Million USD | -841.207% |
| Fortress Biotech, Inc. | 165.93 Million USD | -841.207% |
| Agenus Inc. | 462.29 Million USD | -237.843% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -2084.989% |
| Dyadic International, Inc. | 2.34 Million USD | -66626.308% |
| ImmuCell Corporation | 18.81 Million USD | -8200.972% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -9503.579% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -5433.303% |
| Lantern Pharma Inc. | 2.73 Million USD | -56907.711% |
| Immix Biopharma, Inc. | 3.72 Million USD | -41864.564% |
| Incyte Corporation | 1.59 Billion USD | 1.912% |
| IO Biotech, Inc. | 17.55 Million USD | -8796.275% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -4231.438% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -44160.462% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -3241.599% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -930.829% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -63778.528% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -5577.111% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -564.004% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -215.834% |
| NextCure, Inc. | 14.99 Million USD | -10314.283% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -38540.03% |
| Onconetix, Inc. | 23.18 Million USD | -6637.576% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -23291.194% |
| Opthea Limited | 264.6 Million USD | -490.258% |
| PDS Biotechnology Corporation | 33.25 Million USD | -4595.943% |
| PureTech Health plc | 125.58 Million USD | -1143.664% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -3152.322% |
| Seer, Inc. | 39.36 Million USD | -3867.56% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -120110.954% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -3028.039% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -116841.607% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -17350.615% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -586.685% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -349.344% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1098.301% |
| ChromaDex Corporation | 26.5 Million USD | -5791.919% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -14210.335% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -2052.259% |
| CRISPR Therapeutics AG | 346.76 Million USD | -350.396% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1008.31% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1033.403% |
| Innoviva, Inc. | 568.55 Million USD | -174.703% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1146.9% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -2425.843% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -5636.117% |
| ESSA Pharma Inc. | 3.49 Million USD | -44586.646% |
| GlycoMimetics, Inc. | 6.9 Million USD | -22528.416% |
| GT Biopharma, Inc. | 6.63 Million USD | -23446.359% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -490.73% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1758.746% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -5648.574% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -48317.232% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -2017.248% |
| Aptose Biosciences Inc. | 15.8 Million USD | -9779.559% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -14047.413% |
| Soligenix, Inc. | 7.27 Million USD | -21368.737% |
| Century Therapeutics, Inc. | 175.94 Million USD | -787.701% |
| Kura Oncology, Inc. | 51.66 Million USD | -2923.17% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -1187.767% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -37689.257% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -23514.518% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -518.307% |
| Autolus Therapeutics plc | 263.9 Million USD | -491.811% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -14800.114% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -1657.61% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -3230.199% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -342.625% |
| GRI Bio, Inc. | 2.69 Million USD | -57809.9% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -192817.359% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -4923.415% |
| IGM Biosciences, Inc. | 220.17 Million USD | -609.352% |
| INmune Bio, Inc. | 18.86 Million USD | -8180.299% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -508.95% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -5762.326% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -57353.89% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -47512.907% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -2571.85% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -1524.216% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -489.96% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -89.766% |
| Verastem, Inc. | 71.18 Million USD | -2094.044% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -3076.0% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -3948.499% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -3091.838% |
| Histogen Inc. | 5.69 Million USD | -27314.955% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -35512.646% |
| Surrozen, Inc. | 8.14 Million USD | -19075.322% |
| Organovo Holdings, Inc. | 2.74 Million USD | -56735.153% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -497523.129% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -2677.579% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -9358.757% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -2956.239% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -188783.447% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1132.456% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -14343.215% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -935.085% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -59801.164% |
| Apollomics, Inc. | 14.15 Million USD | -10935.328% |
| Amarin Corporation plc | 279.58 Million USD | -458.62% |
| Mesoblast Limited | 188.79 Million USD | -727.249% |
| Turnstone Biologics Corp. | 14.14 Million USD | -10939.228% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -763.901% |
| Synaptogenix, Inc. | 5.52 Million USD | -28145.569% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -23393.231% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -818.14% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -18151.663% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -88771.983% |
| Exelixis, Inc. | 678.44 Million USD | -130.207% |
| Better Therapeutics, Inc. | 23.84 Million USD | -6450.751% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -852.068% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -162.842% |
| NLS Pharmaceutics AG | 10.68 Million USD | -14523.597% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -96094.544% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -3912.202% |
| Gritstone bio, Inc. | 125.91 Million USD | -1140.345% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -10542.069% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -30592.562% |
| Avid Bioservices, Inc. | 275.66 Million USD | -466.562% |
| Insmed Incorporated | 1.66 Billion USD | 6.014% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -20199.261% |
| MediWound Ltd. | 27.18 Million USD | -5644.768% |
| OmniAb, Inc. | 87.4 Million USD | -1686.991% |
| Alector, Inc. | 487.66 Million USD | -220.264% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -287.113% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -8376.689% |
| Zai Lab Limited | 240.17 Million USD | -550.283% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -147.887% |
| Aura Biosciences, Inc. | 29.22 Million USD | -5243.792% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -1542.7% |
| Immunic, Inc. | 25.36 Million USD | -6056.693% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -2155.806% |
| Veracyte, Inc. | 93.71 Million USD | -1566.503% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -59587.626% |
| FibroGen, Inc. | 585.72 Million USD | -166.648% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -8884.813% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -239049.808% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -27516.331% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 79.601% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -18951.354% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1758.835% |
| TG Therapeutics, Inc. | 169.08 Million USD | -823.695% |
| Galecto, Inc. | 5.89 Million USD | -26389.654% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -18753.573% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 40.352% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -5318.881% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -12274.851% |
| XBiotech Inc. | 8.39 Million USD | -18499.857% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -10542.069% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -2836.875% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -330.131% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -5709.515% |
| Theravance Biopharma, Inc. | 169 Million USD | -824.138% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -28.482% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -212.1% |
| Vaxxinity, Inc. | 30.94 Million USD | -4947.279% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -60.601% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -25796.241% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -109.576% |
| NexImmune, Inc. | 5.08 Million USD | -30619.094% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -420431.834% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -50693.73% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 78.024% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -30203.083% |
| Scopus BioPharma Inc. | 7.45 Million USD | -20851.691% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -5839.872% |
| Ainos, Inc. | 7.39 Million USD | -21022.3% |
| Pluri Inc. | 34.11 Million USD | -4478.535% |
| Prothena Corporation plc | 135.01 Million USD | -1056.765% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -542.456% |
| Celularity Inc. | 102.92 Million USD | -1417.386% |
| Rallybio Corporation | 9.43 Million USD | -16451.823% |
| Cue Biopharma, Inc. | 24.44 Million USD | -6289.159% |
| MeiraGTx Holdings plc | 319.99 Million USD | -388.086% |
| Omeros Corporation | 403.25 Million USD | -287.309% |
| Humacyte, Inc. | 114.67 Million USD | -1261.938% |
| Immunocore Holdings plc | 228.15 Million USD | -584.539% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -31937.538% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1935.223% |
| Blueprint Medicines Corporation | 918.64 Million USD | -70.015% |
| CalciMedica, Inc. | 4.02 Million USD | -38674.33% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -8849.289% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -913.234% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1719.954% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -462.228% |
| Pulmatrix, Inc. | 15.96 Million USD | -9684.063% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -9801.921% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -6247.354% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -522.719% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -2975.315% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -29.009% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -4814.042% |
| Nutriband Inc. | 1.07 Million USD | -144658.782% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -14588.517% |
| Vor Biopharma Inc. | 59.1 Million USD | -2542.512% |
| Roivant Sciences Ltd. | 773.95 Million USD | -101.799% |
| Evogene Ltd. | 17.99 Million USD | -8581.656% |
| ProKidney Corp. | 29.21 Million USD | -5245.804% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -2069.841% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -221441.512% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 17.316% |
| CorMedix Inc. | 11.91 Million USD | -13005.318% |
| BioLineRx Ltd. | 50.7 Million USD | -2980.411% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -944.989% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -1665.957% |
| Atai Life Sciences N.V. | 49.16 Million USD | -3076.905% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -4913.529% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -8595.19% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -1153.113% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -27523.452% |
| MediciNova, Inc. | 3.89 Million USD | -40033.849% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -8444.395% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -103728.442% |
| GeoVax Labs, Inc. | 3.51 Million USD | -44271.671% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -293.152% |
| Biomea Fusion, Inc. | 30.69 Million USD | -4989.052% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 42.616% |
| Mereo BioPharma Group plc | 15.96 Million USD | -9684.676% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -4905.705% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -2561.424% |
| Absci Corporation | 58.3 Million USD | -2578.77% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8099.444% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -4771.281% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -2016.588% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1685.295% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -4524.904% |
| Allakos Inc. | 74.79 Million USD | -1988.203% |
| Imunon, Inc. | 8.53 Million USD | -18208.931% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -6841.158% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -1260.337% |
| BioAtla, Inc. | 48.98 Million USD | -3088.319% |
| NLS Pharmaceutics AG | 10.68 Million USD | -14523.597% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -56101.151% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1095.852% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -10887.197% |
| XOMA Corporation | 145.58 Million USD | -972.833% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -4539.329% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -2171.455% |
| aTyr Pharma, Inc. | 31.59 Million USD | -4842.969% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -2426.293% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -3373.435% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -3126.788% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -54319.164% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -19044.724% |
| Akari Therapeutics, Plc | 4.58 Million USD | -33971.335% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -8707.413% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 5.313% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -386579.64% |
| UroGen Pharma Ltd. | 243.52 Million USD | -541.348% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -386.42% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -56456.118% |
| Orgenesis Inc. | 35.53 Million USD | -4295.188% |
| Entera Bio Ltd. | 1.37 Million USD | -113158.158% |
| GH Research PLC | 6.7 Million USD | -23207.417% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -22868.088% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -8196.133% |
| Xencor, Inc. | 283.55 Million USD | -450.795% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -52210.784% |
| Replimune Group, Inc. | 113.21 Million USD | -1279.538% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -41469.817% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -1408.577% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -386579.64% |
| Portage Biotech Inc. | 4.45 Million USD | -34997.303% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -103728.442% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -6675.835% |
| OncoCyte Corporation | 49.29 Million USD | -3068.141% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -37654.499% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -195744.682% |
| Purple Biotech Ltd. | 10 Million USD | -15510.495% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -26893.26% |
| scPharmaceuticals Inc. | 57.26 Million USD | -2627.563% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -12507.583% |
| HilleVax, Inc. | 78.9 Million USD | -1879.28% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -30827.327% |
| Tharimmune, Inc. | 1.81 Million USD | -85949.059% |
| Genprex, Inc. | 3.25 Million USD | -47894.166% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -5659.173% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -29728.686% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -758069.903% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -435498.581% |
| OKYO Pharma Limited | 7.42 Million USD | -20946.522% |
| Savara Inc. | 37.19 Million USD | -4099.371% |
| Curis, Inc. | 57.61 Million USD | -2610.946% |
| Daré Bioscience, Inc. | 26.32 Million USD | -5831.784% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -3884.281% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -108059.972% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -7401.945% |
| BeiGene, Ltd. | 2.23 Billion USD | 30.08% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -7236.048% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -495.216% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -7241.497% |
| Erasca, Inc. | 78.61 Million USD | -1886.783% |
| bluebird bio, Inc. | 424.62 Million USD | -267.815% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -238255.625% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 17.366% |
| DBV Technologies S.A. | 42.8 Million USD | -3549.136% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -238255.625% |
| Moderna, Inc. | 4.57 Billion USD | 65.839% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -22227.806% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -94213.406% |
| Molecular Templates, Inc. | 31.17 Million USD | -4910.523% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -9049.561% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -165.571% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -1154.432% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -5592.423% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -4184.151% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -2707.28% |
| MacroGenics, Inc. | 154.2 Million USD | -912.814% |
| RenovoRx, Inc. | 4.46 Million USD | -34871.563% |
| Adicet Bio, Inc. | 37.12 Million USD | -4107.516% |
| Prime Medicine, Inc. | 60.78 Million USD | -2469.645% |
| Aditxt, Inc. | 28.53 Million USD | -5374.044% |
| Adagene Inc. | 45.16 Million USD | -3357.721% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -864217.298% |
| Quantum-Si incorporated | 26.63 Million USD | -5764.707% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -123.897% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -51234.818% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -1258.574% |
| SciSparc Ltd. | 1.59 Million USD | -97820.376% |
| Vericel Corporation | 127.7 Million USD | -1122.998% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -27965.764% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1729.738% |
| Generation Bio Co. | 171.63 Million USD | -809.998% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -13422.338% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -3633.666% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -518.062% |
| Invivyd, Inc. | 51.71 Million USD | -2920.188% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -1598.066% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -23908.758% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -1968.759% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -152870.617% |
| 2seventy bio, Inc. | 310.12 Million USD | -403.611% |
| ADMA Biologics, Inc. | 193.97 Million USD | -705.167% |
| Clene Inc. | 38.95 Million USD | -3909.73% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -4222.464% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -507.773% |
| GeoVax Labs, Inc. | 3.51 Million USD | -44271.671% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -720.88% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -12723.262% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -687.522% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -12707.344% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -3146.305% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -2855.716% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -322.283% |
| Evaxion Biotech A/S | 17.61 Million USD | -8765.229% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -870.509% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -919.564% |
| Trevena, Inc. | 48.26 Million USD | -3136.149% |
| Surrozen, Inc. | 8.14 Million USD | -19075.322% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -7132.369% |
| Cingulate Inc. | 10.36 Million USD | -14974.321% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -56693.818% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -4088.11% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -43447.227% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -11777.034% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -392.379% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -6185.283% |
| Clearmind Medicine Inc. | 3.61 Million USD | -43163.893% |
| Kronos Bio, Inc. | 54.2 Million USD | -2781.552% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -3220.005% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -6762.251% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -7681.526% |
| Statera Biopharma, Inc. | 22.67 Million USD | -6787.453% |
| ImmunityBio, Inc. | 1.09 Billion USD | -43.236% |
| Korro Bio, Inc. | 51.75 Million USD | -2917.912% |
| Kineta, Inc. | 7.22 Million USD | -21526.004% |
| BioVie Inc. | 9.7 Million USD | -15997.805% |
| Codexis, Inc. | 49.94 Million USD | -3027.037% |
| Celularity Inc. | 102.92 Million USD | -1417.386% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -1522.731% |
| Celcuity Inc. | 51.45 Million USD | -2935.622% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -452349.927% |
| Cibus, Inc. | 206.11 Million USD | -657.74% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -3577.057% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -5829.724% |
| IN8bio, Inc. | 8.77 Million USD | -17704.72% |
| Kodiak Sciences Inc. | 213.59 Million USD | -631.225% |
| Annexon, Inc. | 47.11 Million USD | -3214.72% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -1644.262% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -1520.626% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -11309.38% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 40.008% |
| Eyenovia, Inc. | 19.78 Million USD | -7795.894% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -781.961% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -20233.681% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -6380.891% |
| Arcellx, Inc. | 339.75 Million USD | -359.697% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -13026.828% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -536.08% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -16232.009% |
| Moolec Science SA | 13.94 Million USD | -11099.642% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -3519.369% |
| Geron Corporation | 146.12 Million USD | -968.817% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -2990.774% |
| Royalty Pharma plc | 6.29 Billion USD | 75.199% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -3826.564% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -530402.096% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -63381.747% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -725.684% |
| Humacyte, Inc. | 114.67 Million USD | -1261.938% |
| Structure Therapeutics Inc. | 29.05 Million USD | -5276.165% |
| 89bio, Inc. | 59.96 Million USD | -2504.656% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -5801.939% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -130487.793% |
| Genelux Corporation | 8.42 Million USD | -18449.05% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -22680.484% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1045.717% |
| Notable Labs, Ltd. | 4.42 Million USD | -35179.648% |
| Liquidia Corporation | 73.13 Million USD | -2035.456% |
| Mustang Bio, Inc. | 17.61 Million USD | -8764.464% |
| Immunovant, Inc. | 48.95 Million USD | -3090.338% |
| Quantum-Si incorporated | 26.63 Million USD | -5764.707% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -3969.067% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -50232.904% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -2014.553% |
| Acasti Pharma Inc. | 11.55 Million USD | -13414.147% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -6808.389% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -57353.89% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -4135.241% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -114500.959% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -25520.571% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -6188.826% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -6636.672% |
| PepGen Inc. | 34.63 Million USD | -4409.919% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -12760.919% |
| United Therapeutics Corporation | 1.18 Billion USD | -32.112% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -22262.973% |
| Solid Biosciences Inc. | 38.45 Million USD | -3961.132% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -18151.663% |
| Immuneering Corporation | 12 Million USD | -12906.194% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -497523.129% |
| Silo Pharma, Inc. | 1.56 Million USD | -99425.894% |
| Belite Bio, Inc | 4.21 Million USD | -36989.29% |
| XOMA Corporation | 145.58 Million USD | -972.833% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -64225.783% |
| Bionomics Limited | 10.15 Million USD | -15274.278% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -7167.368% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -6716.349% |
| uniQure N.V. | 624.01 Million USD | -150.286% |
| Cassava Sciences, Inc. | 14.19 Million USD | -10902.677% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -864217.298% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -817.73% |
| Forte Biosciences, Inc. | 3.66 Million USD | -42503.11% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -599259.897% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -23048.51% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -20233.681% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -8884.813% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -14678.861% |
| Altimmune, Inc. | 16.54 Million USD | -9342.174% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -152.844% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -6716.349% |
| Compugen Ltd. | 55.77 Million USD | -2700.233% |
| Peak Bio, Inc. | 20.75 Million USD | -7425.672% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -1313.894% |
| Benitec Biopharma Inc. | 4.96 Million USD | -31375.816% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -889.483% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -1977.62% |
| Zura Bio Limited | 21.29 Million USD | -7235.29% |
| PolyPid Ltd. | 17.46 Million USD | -8841.092% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -1289.541% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -1977.62% |
| Instil Bio, Inc. | 99.8 Million USD | -1464.944% |
| argenx SE | 444.95 Million USD | -251.012% |
| Immunome, Inc. | 28.65 Million USD | -5349.892% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -18633.717% |
| Verona Pharma plc | 58.84 Million USD | -2554.323% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -10691.336% |
| Shattuck Labs, Inc. | 14.85 Million USD | -10411.003% |
| CervoMed Inc. | 2.59 Million USD | -60068.807% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -31944.112% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -12163.112% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -14725.154% |
| Moolec Science SA | 13.94 Million USD | -11099.642% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -66545.075% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -2709.285% |
| AnaptysBio, Inc. | 364.28 Million USD | -328.737% |
| Design Therapeutics, Inc. | 11.95 Million USD | -12963.148% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -12213.387% |
| NeurAxis, Inc. | 1.91 Million USD | -81554.11% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -3912.099% |
| Lumos Pharma, Inc. | 13.33 Million USD | -11614.018% |
| Achilles Therapeutics plc | 19.08 Million USD | -8082.69% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -10691.336% |
| 180 Life Sciences Corp. | 5.38 Million USD | -28891.45% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -6521.293% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -6762.251% |
| Nutriband Inc. | 1.07 Million USD | -144658.782% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -5004.353% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -10663.076% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -289.218% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -4709.626% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -11868.875% |
| Palisade Bio, Inc. | 2.73 Million USD | -56921.906% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -29632.153% |
| Beam Therapeutics Inc. | 478.38 Million USD | -226.48% |
| Neurogene Inc. | 36.54 Million USD | -4173.25% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -292.468% |
| AEON Biopharma, Inc. | 159.88 Million USD | -876.821% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -3177.712% |
| Sesen Bio, Inc. | 30.98 Million USD | -4940.763% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -5916.063% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -20444.404% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -697.919% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -713.212% |
| Athira Pharma, Inc. | 30.05 Million USD | -5096.227% |
| Vaccinex, Inc. | 5.94 Million USD | -26184.584% |
| HCW Biologics Inc. | 15.05 Million USD | -10276.268% |
| XOMA Corporation | 145.58 Million USD | -972.833% |
| Nektar Therapeutics | 267.04 Million USD | -484.854% |
| Arvinas, Inc. | 644.6 Million USD | -142.294% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -8707.413% |
| Merus N.V. | 102.15 Million USD | -1428.942% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -967.188% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -1541.958% |
| Rezolute, Inc. | 11.73 Million USD | -13210.295% |
| Clene Inc. | 38.95 Million USD | -3909.73% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -54751.477% |
| BeyondSpring Inc. | 48.26 Million USD | -3135.679% |
| Synlogic, Inc. | 32.89 Million USD | -4647.925% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -10587.949% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -95483.231% |
| Peak Bio, Inc. | 20.75 Million USD | -7425.672% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -2361.164% |
| Krystal Biotech, Inc. | 39.71 Million USD | -3832.694% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -314.67% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -1468.591% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -360828.162% |
| MannKind Corporation | 721.36 Million USD | -116.51% |
| Ikena Oncology, Inc. | 22.33 Million USD | -6892.747% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -74772.004% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -1422.4% |
| Gossamer Bio, Inc. | 249.14 Million USD | -526.871% |
| CohBar, Inc. | 1.03 Million USD | -151000.288% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -14511.563% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8099.444% |
| Legend Biotech Corporation | 589.93 Million USD | -164.747% |
| Mural Oncology plc | 37.92 Million USD | -4017.881% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1077.531% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -67943.751% |
| Disc Medicine, Inc. | 22.87 Million USD | -6727.672% |
| Champions Oncology, Inc. | 28.03 Million USD | -5471.001% |
| REGENXBIO Inc. | 262.22 Million USD | -495.6% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -46392.002% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -12360.747% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -11528.003% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -7265.386% |
| Vaxart, Inc. | 34.02 Million USD | -4490.242% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -7560.061% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -5373.982% |
| Cellectis S.A. | 249.57 Million USD | -525.796% |
| Longeveron Inc. | 5.33 Million USD | -29164.193% |
| Repare Therapeutics Inc. | 41.81 Million USD | -3634.738% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 35.065% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -2487.182% |
| Revolution Medicines, Inc. | 262.39 Million USD | -495.216% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -74025.771% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -18006.075% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -13134.726% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -11021.769% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -72509.484% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 69.672% |
| Denali Therapeutics Inc. | 122.96 Million USD | -1170.163% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -27965.764% |
| Veru Inc. | 32.81 Million USD | -4659.833% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -22637.371% |
| Cingulate Inc. | 10.36 Million USD | -14974.321% |
| Passage Bio, Inc. | 39.26 Million USD | -3877.969% |
| Context Therapeutics Inc. | 4.19 Million USD | -37159.928% |
| Exicure, Inc. | 8.54 Million USD | -18169.154% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -5192.904% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -14794.431% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -6986.022% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -858.26% |
| Nuvalent, Inc. | 31.82 Million USD | -4807.865% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -24450.795% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -2378.23% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -8576.833% |
| OmniAb, Inc. | 87.4 Million USD | -1686.991% |
| Anew Medical, Inc. | 8.24 Million USD | -18850.11% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -3979.047% |
| Lipocine Inc. | 2.63 Million USD | -59248.411% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -5844.846% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -3783.99% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -5762.326% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1712.835% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -28817.423% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1787.476% |
| Ocugen, Inc. | 23.98 Million USD | -6412.238% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -3265.505% |
| Q32 Bio Inc. | 233.12 Million USD | -569.945% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -17127.333% |
| Alumis Inc. Common Stock | 53.5 Million USD | -2819.199% |
| Equillium, Inc. | 27.95 Million USD | -5486.544% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -655.997% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -27657.65% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -25366.136% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -892.735% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -2149.406% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -15558.698% |
| Dominari Holdings Inc. | 4.63 Million USD | -33596.44% |
| Edesa Biotech, Inc. | 1.84 Million USD | -84706.615% |
| vTv Therapeutics Inc. | 29.56 Million USD | -5182.342% |
| Bio-Techne Corporation | 744.34 Million USD | -109.827% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1138.574% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -353.419% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -3749.242% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -5293.618% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -1591.024% |
| Nkarta, Inc. | 105.6 Million USD | -1379.006% |
| BioCardia, Inc. | 4.59 Million USD | -33926.797% |
| Iterum Therapeutics plc | 32.66 Million USD | -4681.795% |